“…Based on a review of the literature we chose JC70, an anti-CD31 antibody, as marker for the microvessels as this endothelial marker is the most sensitive and specific of all and it does not react with lymphatic endothelium (Parums et al, 1990;Horak et al, 1992;Kuzu et al, 1992). However, of the seven previously published studies about invasive cervical cancer and angiogenesis, six used factor VIII (Kainz et al, 1995;Rutgers et al, 1995;Schlenger et al, 1995;Wiggens et al, 1995;Dinh et al, 1996;Abulafia et al, 1996), one Ulex europeaus lectin I (Bremer et al, 1996) and none CD31 as endothelial marker.…”